Mark Holck

652 total citations
20 papers, 571 citations indexed

About

Mark Holck is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mark Holck has authored 20 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mark Holck's work include Receptor Mechanisms and Signaling (9 papers), Cardiac electrophysiology and arrhythmias (8 papers) and Ion channel regulation and function (7 papers). Mark Holck is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Cardiac electrophysiology and arrhythmias (8 papers) and Ion channel regulation and function (7 papers). Mark Holck collaborates with scholars based in Switzerland, Austria and Canada. Mark Holck's co-authors include Wolfgang Osterrieder, Bernard H. Marks, G. Haeusler, Guenther Haeusler, M Gerold, Walter Fischli, Franz Hefti, Urs Hengartner, Fridolin Hefti and Emanuel Escher and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Mark Holck

20 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Holck Switzerland	13	379	245	219	97	49	20	571
James K. Woodward United States	14	288 0.8×	263 1.1×	171 0.8×	149 1.5×	32 0.7×	23	770
G. P�ch Austria	10	451 1.2×	223 0.9×	134 0.6×	324 3.3×	99 2.0×	15	861
Hiromichi Nakajima United States	15	375 1.0×	245 1.0×	168 0.8×	88 0.9×	146 3.0×	42	788
R H Poyser United Kingdom	12	280 0.7×	245 1.0×	97 0.4×	65 0.7×	116 2.4×	32	610
Michio Terai United Kingdom	11	362 1.0×	73 0.3×	240 1.1×	99 1.0×	75 1.5×	24	613
V.C. Swamy United States	12	375 1.0×	136 0.6×	178 0.8×	172 1.8×	50 1.0×	26	594
P B Timmermans United States	9	587 1.5×	578 2.4×	230 1.1×	138 1.4×	60 1.2×	14	967
F Lefèvre-Borg France	18	398 1.1×	170 0.7×	300 1.4×	193 2.0×	74 1.5×	28	821
Tsuyoshi Ohmura Japan	15	485 1.3×	121 0.5×	285 1.3×	259 2.7×	17 0.3×	30	846
Steven A. Buckner United States	19	434 1.1×	109 0.4×	154 0.7×	112 1.2×	251 5.1×	57	986

Countries citing papers authored by Mark Holck

Since Specialization

Citations

This map shows the geographic impact of Mark Holck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Holck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Holck more than expected).

Fields of papers citing papers by Mark Holck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Holck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Holck. The network helps show where Mark Holck may publish in the future.

Co-authorship network of co-authors of Mark Holck

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Holck. A scholar is included among the top collaborators of Mark Holck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Holck. Mark Holck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Holck, Mark, et al.. (1989). An angiotensin II antagonist with strongly prolonged action. Biochemical and Biophysical Research Communications. 160(3). 1350–1356. 15 indexed citations

2.

Holck, Mark, et al.. (1989). In vitro pharmacological properties of a series of isoprenaline derivatives.. PubMed. 39(8). 842–7. 3 indexed citations

3.

Osterrieder, Wolfgang & Mark Holck. (1989). In Vitro Pharmacologic Profile of Ro 40-5967, a Novel Ca2+ Channel Blocker with Potent Vasodilator but Weak Inotropic Action. Journal of Cardiovascular Pharmacology. 13(5). 754–759. 84 indexed citations

4.

Osterrieder, Wolfgang & Mark Holck. (1989). In Vitro Pharmacologic Profile of Ro 40-5967, a Novel Ca2+ Channel Blocker with Potent Vasodilator but Weak Inotropic Action. Journal of Cardiovascular Pharmacology. 13(5). 754–759. 94 indexed citations

5.

Holck, Mark. (1988). α1-adrenoceptor reserve and effects of a Ca2+ entry blocker (Ro 18-3981) on aorta of spontaneously hypertensive rats. European Journal of Pharmacology. 148(1). 9–15. 8 indexed citations

6.

Holck, Mark & Wolfgang Osterrieder. (1988). Interaction of the Cardiotonic Agent DPI 201-106 with Cardiac Ca2+ Channels. Journal of Cardiovascular Pharmacology. 11(4). 478–482. 23 indexed citations

7.

Schmidhammer, Helmut, et al.. (1988). (−)‐N‐[(Cyclopropyl) methyl]‐3,4‐dimethoxy‐5‐methylmorphinan‐6‐one, an opioid agonist with preference for kappa opioid receptors. Helvetica Chimica Acta. 71(3). 642–647. 18 indexed citations

8.

Clozel, Jean‐Paul, Mark Holck, Wolfgang Osterrieder, W.P. Burkard, & M. Da Prada. (1987). Effects of chronic myocardial infarction on responsiveness to isoprenaline and the state of myocardial beta adrenoceptors in rats. Cardiovascular Research. 21(9). 688–695. 12 indexed citations

9.

Holck, Mark & Wolfgang Osterrieder. (1987). Inhibition of myocardial Ca²⁺ channels by three dihydropyridines with different structural features: potential‐dependent blockade by Ro 18–3981. British Journal of Pharmacology. 91(1). 61–67. 6 indexed citations

10.

Kozlowski, Roland Z., et al.. (1986). o-Isothiocyanate dihydropyridine (oNCS-DHP), a long-acting, reversible inhibitor of the Ca++ channel.. Journal of Pharmacology and Experimental Therapeutics. 238(3). 1084–1091. 2 indexed citations

11.

Holck, Mark, Walter Fischli, Franz Hefti, & M Gerold. (1986). Cardiovascular Effects of the New Angiotensin-Converting-Enzyme Inhibitor, Cilazapril, in Anesthetized and Conscious Dogs. Journal of Cardiovascular Pharmacology. 8(1). 99–108. 25 indexed citations

12.

Holck, Mark & M Gerold. (1985). Calcium entry blockers inhibit vasoconstrictor responses to sympathetic nerve stimulation mediated by ?1-adrenoceptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 330(1). 22–32. 10 indexed citations

13.

Holck, Mark & Wolfgang Osterrieder. (1985). The peripheral high affinity benzodiazepine binding site is not coupled to the cardiac Ca2+ channel. European Journal of Pharmacology. 118(3). 293–301. 44 indexed citations

14.

Holck, Mark, Walter Fischli, & Urs Hengartner. (1984). Effects of Temperature and Allosteric Modulators on [³H]Nitrendipine Binding: Methods for Detecting Potential Ca²⁺Channel Blockers. Journal of Receptor Research. 4(1-6). 557–569. 12 indexed citations

15.

Gerold, M, et al.. (1984). Cardiovascular Profile of Ro 13–6438, a Novel Positive Inotropic Agent with Vasodilating Properties. Journal of Cardiovascular Pharmacology. 6(3). 511–519. 13 indexed citations

16.

Holck, Mark, et al.. (1983). Does [³H]Nifedipine Label the Calcium Channel in Rabbit Myocardium?. Journal of Receptor Research. 3(1-2). 191–198. 12 indexed citations

17.

Holck, Mark, et al.. (1983). Differential Interactions of Clonidine and Methoxamine with the Postsynaptic α-Adrenoceptor of Rabbit Main Pulmonary Artery. Journal of Cardiovascular Pharmacology. 5(2). 240–248. 53 indexed citations

18.

Holck, Mark, et al.. (1982). Characterization of [3H]nifedipine binding sites in rabbit myocardium. European Journal of Pharmacology. 85(3-4). 305–315. 65 indexed citations

19.

Holck, Mark, et al.. (1979). Characterization of Alpha-Adrenergic Receptors in Guinea-pig Vas Deferens by [3H]Dihydroergocryptine Binding. Molecular Pharmacology. 16(1). 77–90. 7 indexed citations

20.

Holck, Mark & Bernard H. Marks. (1978). Purine nucleoside and nucleotide interactions on normal and subsensitive alpha adrenoreceptor responsiveness in guinea-pig vas deferens.. Journal of Pharmacology and Experimental Therapeutics. 205(1). 104–117. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact